Home > Healthcare > Medical Devices > Diagnostic Devices > Mobile Cardiac Telemetry Systems Market

Mobile Cardiac Telemetry Systems Market Trends

  • Report ID: GMI9376
  • Published Date: May 2024
  • Report Format: PDF

Mobile Cardiac Telemetry Systems Market Trends

The increasing incidence of cardiac disorders is a significant driver for market. Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality worldwide, affecting millions of individuals each year.
 

  • For instance, according to the World Health Organization (WHO), in 2023, cardiovascular diseases (CVDs) are the leading cause of death globally taking an estimated 17.9 million lives each year.
  • Similarly, as per World Heart Federation in 2023, deaths from cardiovascular disease (CVD) jumped globally from 12.1 million in 1990 to 20.5 million in 2021.
     
  • MCT systems offer continuous real-time monitoring of cardiac activity over an extended period enabling the detection of transient arrhythmias, ischemic changes, and other abnormalities that may go unnoticed with intermittent monitoring approaches. Further, continuous monitoring with these systems allows for early detection of cardiac events and stroke management, facilitating timely intervention and reducing the risk of complications.
     
  • Modern MCT devices are compact, lightweight, and discreet, allowing patients to wear them comfortably for extended periods without interference with their daily activities. These advancements have expanded the applicability of MCT systems across a wide range of patient populations, including those with complex cardiac conditions or high-risk profiles, thereby increasing the growth of the market.
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Mobile cardiac telemetry (MCT) systems market size was valued at USD 1.1 billion in 2023 and is estimated to grow at 12.1% CAGR from 2024 to 2032, driven by growing aging population.

Lead-based mobile cardiac telemetry (MCT) market is estimated to account for USD 1.9 billion in revenue by the end of 2032, owing to their wide accepted in clinical practice.

U.S. mobile cardiac telemetry systems market is anticipated to grow at 11.7% CAGR during 2024 to 2032 owing to a high prevalence of cardiovascular diseases.

ACS Diagnostics, Baxter International Inc., BIOTRICITY INC., Boston Scientific Cardiac Diagnostics Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Medicomp Systems, ScottCare Cardiovascular Solutions, Telerhythmics LLC, and Zoll Medical Corporation among others.

Mobile Cardiac Telemetry Systems Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 191
  • Countries covered: 23
  • Pages: 105
 Download Free Sample